Novo Nordisk India sales jump 40% after semaglutide price cuts
Business
Novo Nordisk just saw its diabetes and weight-loss drug sales in India jump 40% in April 2026, right after slashing prices on Ozempic and Wegovy by up to 48%.
Now starting at ₹5,660 (about $60), these meds got cheaper as India became the first country with generic versions of semaglutide, their main ingredient.
Branded drugs keep selling despite generics
Even with new GLP-1 generics selling for as low as $14 a month and market volume up 56%, branded drugs like Ozempic and Wegovy are still holding strong with 32,000 units sold in April.
According to Pharmarack's Sheetal Sapale, generics have mostly helped more people access treatment but haven't really cut into the popularity of big-name brands, especially since many doctors and patients still prefer them.